Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.9600
+0.1227 (14.65%)
At close: Apr 15, 2026, 4:00 PM EDT
0.9800
+0.0200 (2.08%)
After-hours: Apr 15, 2026, 7:41 PM EDT
RANI Stock Forecast
Stock Price Forecast
The 4 analysts that cover RANI stock have a consensus rating of "Strong Buy" and an average price target of $7.50, which forecasts a 681.25% increase in the stock price over the next year. The lowest target is $4.00 and the highest is $11.
Price Target: $7.50 (+681.25%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for RANI stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $9 → $5 | Strong Buy | Maintains | $9 → $5 | +420.83% | Apr 1, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +1,045.83% | Mar 27, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +1,045.83% | Jan 9, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +1,045.83% | Oct 21, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $5 → $10 | Strong Buy | Maintains | $5 → $10 | +941.67% | Oct 20, 2025 |
Financial Forecast
Revenue This Year
6.89M
from 1.63M
Increased by 321.62%
Revenue Next Year
11.49M
from 6.89M
Increased by 66.86%
EPS This Year
-0.21
from -0.45
EPS Next Year
-0.20
from -0.21
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 18.9M | 18.9M | |||
| Avg | 6.9M | 11.5M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1,057.4% | 174.5% | |||
| Avg | 321.6% | 66.9% | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.14 | -0.19 | |||
| Avg | -0.21 | -0.20 | |||
| Low | -0.29 | -0.24 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.